Meeting
2023 ASCO Annual Meeting
Correlation of gene signatures of Kaiso and LC3A/B protein expression with distinct tumor ecosystems and to predict response to breast cancer therapy.
Authors
Sandeep K. Singhal
Department of Pathology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND
Sandeep K. Singhal , Kevin Gardner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 566)
DOI
10.1200/JCO.2023.41.16_suppl.566
Abstract #
566
Poster Bd #
396
Abstract Disclosures
Similar Posters
Poster
2012 Breast Cancer Symposium
Long-term outcome after neoadjuvant radiochemotherapy in locally advanced noninflammatory breast cancer and predictive factors for a pathologic complete remission: Results of a multivariate analysis.
First Author: Christiane Matuschek
Poster
2011 ASCO Annual Meeting
Use of topoisomerase 2 alpha (TOP2A) protein overexpression to predict response to anthracycline-based chemotherapy.
First Author: S. Chan
Poster
2023 ASCO Annual Meeting
Oral paclitaxel, carboplatin, and dostarlimab (OPE/Cb/D) without and with trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant I-SPY 2 TRIAL.
First Author: Kay T Yeung
Poster
2023 ASCO Annual Meeting
Oral paclitaxel and dostarlimab with or without trastuzumab in early-stage, high-risk breast cancer: Results from the neoadjuvant ISPY 2 TRIAL.
First Author: Rebecca Arielle Shatsky